$1.1 B

BABY Mkt cap, 18-Oct-2018

$259.3 M

Natus Medical Revenue Q2, 2018
Natus Medical Gross profit (Q2, 2018)151 M
Natus Medical Gross profit margin (Q2, 2018), %58.2%
Natus Medical Net income (Q2, 2018)-5.7 M
Natus Medical EBIT (Q2, 2018)-6.5 M
Natus Medical Cash, 31-Dec-201789 M
Natus Medical EV1.1 B

Natus Medical Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

344.1m355.8m375.9m381.9m501.0m

Revenue growth, %

3%6%2%

Cost of goods sold

142.1m145.5m144.6m213.4m

Gross profit

202.0m230.4m237.3m287.6m

Gross profit Margin, %

59%61%62%57%

R&D expense

33.4m51.8m

General and administrative expense

50.9m74.4m

Operating expense total

84.3m272.5m

EBIT

34.3m45.9m53.5m55.3m8.7m

EBIT margin, %

10%13%14%14%2%

Income tax expense

25.4m

Net Income

22.9m32.5m37.9m42.6m(20.3m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Revenue

85.4m85.6m86.3m89.9m89.4m91.9m94.6m87.3m96.0m90.9m124.7m122.2m128.6m259.3m

Cost of goods sold

34.1m35.7m35.3m34.3m35.1m33.8m35.5m32.5m37.9m32.2m56.9m54.6m55.4m108.3m

Gross profit

51.3m49.9m51.0m55.5m54.3m58.1m59.1m54.9m58.1m58.7m67.7m67.6m73.2m151.0m

Gross profit Margin, %

60%58%59%62%61%63%62%63%61%65%54%55%57%58%

R&D expense

7.5m7.5m7.9m8.2m6.9m7.3m7.7m7.8m7.1m7.7m12.8m13.7m15.4m31.1m

General and administrative expense

14.3m12.3m10.8m14.7m11.6m11.7m10.0m12.5m11.9m12.8m16.0m24.2m17.4m41.2m

Operating expense total

42.2m41.2m40.7m42.8m40.3m43.4m42.3m43.0m43.5m42.9m65.3m72.4m74.4m153.2m

EBIT

9.1m8.7m10.3m12.8m13.3m14.0m16.1m11.2m13.9m15.2m1.4m(6.3m)(2.7m)(6.5m)

EBIT margin, %

11%10%12%14%15%15%17%13%15%17%1%(5%)(2%)(3%)

Income tax expense

2.3m(1.4m)(5.0m)

Net Income

6.3m6.3m7.7m7.8m8.6m9.9m10.9m8.5m10.5m13.3m348.0k(5.0m)(3.1m)(5.7m)

Natus Medical Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

56.1m66.6m82.5m213.6m89.0m

Accounts Receivable

Inventories

37.7m40.1m48.6m49.6m71.5m

Current Assets

196.8m217.8m241.4m405.8m305.6m

PP&E

23.3m17.9m17.0m17.3m22.1m

Goodwill

97.2m96.3m107.5m113.1m173.0m

Total Assets

426.4m434.8m479.5m649.0m709.9m

Accounts Payable

29.8m21.4m23.7m18.7m25.2m

Short-term debt

10.5m10.5m

Current Liabilities

80.1m69.1m77.1m79.9m92.1m

Long-term debt

27.5m27.5m140.0m154.3m

Total Debt

38.0m38.0m140.0m154.3m

Total Liabilities

231.6m287.8m

Retained Earnings

34.5m68.9m106.8m149.4m129.1m

Total Equity

306.3m352.7m390.7m417.4m422.1m

Debt to Equity Ratio

0.1 x0.1 x0.3 x0.4 x

Debt to Assets Ratio

0.1 x0.1 x0.2 x0.2 x

Financial Leverage

1.4 x1.2 x1.2 x1.6 x1.7 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

44.2m59.6m56.0m57.8m67.0m73.2m82.2m81.3m96.3m81.1m103.8m80.3m

Inventories

39.4m35.5m35.5m37.1m41.4m44.9m46.1m45.7m43.6m51.7m67.7m69.3m

Current Assets

182.6m198.3m189.9m193.3m218.2m228.4m247.5m228.3m245.9m266.0m316.5m287.0m

PP&E

24.4m21.5m21.1m19.3m18.2m18.4m18.0m17.6m17.2m18.1m20.9m20.9m

Goodwill

97.3m100.9m100.9m97.1m109.3m108.5m108.4m112.9m110.9m111.9m185.8m176.7m

Total Assets

415.8m429.3m419.7m415.0m443.7m453.9m469.9m472.7m486.1m510.7m688.9m662.6m

Accounts Payable

26.5m26.1m25.0m26.5m22.3m19.3m24.2m19.4m18.8m17.1m26.1m26.8m

Short-term debt

10.6m10.4m10.4m8.0m10.0m

Current Liabilities

75.4m74.0m70.2m69.4m71.4m66.4m73.6m67.8m77.4m89.2m85.5m86.2m

Long-term debt

37.5m22.5m6.0m

Total Debt

48.1m32.9m16.4m8.0m10.0m

Total Liabilities

127.1m109.5m89.3m83.1m85.2m80.1m89.1m80.4m89.9m101.3m268.4m236.1m

Retained Earnings

25.4m40.8m48.5m56.3m77.5m87.3m98.3m115.4m125.9m139.2m149.8m144.7m

Total Equity

288.7m319.8m330.4m331.8m373.8m380.8m392.4m396.2m409.4m420.4m426.5m

Financial Leverage

1.4 x1.3 x1.3 x1.3 x1.2 x1.2 x1.2 x1.2 x1.2 x1.6 x1.6 x

Natus Medical Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

22.9m32.5m37.9m42.6m(20.3m)

Depreciation and Amortization

12.8m11.8m16.0m16.9m30.1m

Accounts Receivable

9.4m(2.4m)(15.0m)19.7m(30.5m)

Inventories

(2.3m)(2.0m)(12.0m)(7.7m)7.6m

Accounts Payable

(1.4m)(7.6m)3.3m(5.0m)(1.4m)

Cash From Operating Activities

36.8m42.1m36.9m72.7m19.7m

Purchases of PP&E

(1.8m)(4.2m)(4.1m)(3.2m)(4.1m)

Cash From Investing Activities

(22.3m)(10.6m)(19.5m)(53.3m)(160.9m)

Cash From Financing Activities

17.2m(20.9m)832.0k118.4m5.8m

Interest Paid

1.3m434.0k41.0k4.5m

Income Taxes Paid

12.9m5.7m10.2m16.3m5.7m

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Net Income

6.3m6.3m7.7m7.8m8.6m9.9m10.9m8.5m10.5m13.3m348.0k(3.1m)(5.7m)

Depreciation and Amortization

7.9m16.7m

Accounts Receivable

(2.2m)2.1m

Inventories

35.5m37.1m41.4m44.9m46.1m45.7m43.6m51.7m67.7m2.9m(2.5m)

Accounts Payable

25.0m26.5m22.3m19.3m24.2m19.4m18.8m17.1m26.1m(622.0k)(364.0k)

Cash From Operating Activities

6.3m11.3m

Purchases of PP&E

(2.5m)(3.4m)

Cash From Investing Activities

(2.5m)(3.5m)

Cash From Financing Activities

(29.3m)(36.0m)

Interest Paid

1.5m3.0m

Income Taxes Paid

1.7m7.2m
Report incorrect company information